Raheleh Salari, Ph.D

Examiner
DISC Type : cs

VP of Precision Oncology, R&D at Tempus AI

San Francisco Bay Area, United States

Overview

Raheleh Salari is the Vice President of Precision Oncology at Tempus AI, leading R&D for next-generation liquid biopsy platforms. A graduate of Stanford University, she previously spearheaded the creation of Signatera at Natera, establishing the industrys first personalized test for molecular recurrence monitoring, which became a new gold standard.

She is passionate about harnessing AI and multi-modal diagnostics to improve global cancer outcomes. Raheleh is an engaged leader in her field, actively participating in conversations with other leading voices to shape the future of Life Sciences and is focused on growing her team to enhance patient-centric technology.

Unique fact: She was a driving force behind the research, development, and validation of the industrys first personalized Minimal Residual Disease (MRD) test.

Personality Overview

Unexpressive

Tough To Convince

Status Quo Seeker

They are heavily focused on quality and prefer doing things the right way, even if it takes time.  They tend to be clear about their needs and limitations and are unlikely to promise too much. They are always well-planned and adopt a systematic approach.

Topics They Care About

AI in Healthcare
Her current work at Tempus is centered on harnessing AI for diagnostics. She also follows and promotes AI applications in other fields like IVF technology.
Precision Oncology
As VP of Precision Oncology, she is a key leader in the field, focused on developing advanced, AI-driven diagnostics to de-risk cancer recurrence for patients.
Liquid Biopsy R&D
She leads the R&D strategy for next-generation liquid biopsy platforms at Tempus, aiming to revolutionize disease detection and treatment response monitoring.

Media Appearances

Raheleh has no verified media appearances

Work History

4-2025
VP of Precision Oncology, R&D at Tempus AI
9-2022 - 9-2024
VP of Bioinformatics at Natera
3-2021 - 8-2022
Senior Director, Bioinformatics at Natera
3-2016 - 2-2021
Director, Bioinformatics at Natera
11-2010 - 12-2011
Research Fellow at National Institutes of Health

Education

Postgraduate Degree from Stanford University
PhD from Simon Fraser University

More Information

Social Presence :

Prographics :

Exp : 10 Location : San Francisco Bay Area, United States Job Level : Senior Designation : VP of Precision Oncology, R&D at Tempus AI
URL has been copied!

Insights For Selling To Raheleh

During A Call Or A Meeting

DO's

  • Ask them which other stakeholders would be important for this purchase decision
  • First of all, focus on building their confidence by sharing examples, case studies etc.
  • Expect them to be slow and cautious, encourage them to ask more questions

DONT's

  • Don't rely on relationship building even if they act pleasantly
  • Don't be very accepting if that is your natural style, stay firm
  • Don't push them too hard to make fast decisions, give them time

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Raheleh is

  • For them, low risk and acceptance by others are very important, followed by proof of ROI.
  • Will you ever get a clear answer from Raheleh

  • Often, they don't say no, or keep going about it in circles.

Insights For Deal Planning

    How fast (or slow) will Raheleh move?

  • They do not like to take decisions in a hurry, so they could be slow in making their mind up.
  • Can Raheleh take some risk or not?

  • They are low on risk-appetite and prefer to make informed decisions.

You And Raheleh

Personality Compatibility


Other Tempus AI Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.